Alterity Therapeutics (PRNAD) Depreciation & Amortization - Total (2009 - 2025)

Alterity Therapeutics (PRNAD) has reported Depreciation & Amortization - Total for 6 consecutive years, with $36615.2 the latest figure, recorded in Q4 2025.

• In Q4 2025, Depreciation & Amortization - Total changed 0.47% year-over-year to $36615.2; the TTM figure through Dec 2025 stood at $73058.3 (up 0.61% YoY), while the FY2024 annual figure was $73.9 billion, up 71.74% from the prior year.
• Depreciation & Amortization - Total came in at $36615.2 for Q4 2025 at Alterity Therapeutics, roughly flat from $36443.0 in the prior quarter.
• The five-year high for Depreciation & Amortization - Total was $36615.2 in Q4 2025, with the low at $19923.5 in Q4 2022.
• Average Depreciation & Amortization - Total over 4 years is $32288.0, with a median of $36306.7 recorded in 2024.
• Across the five-year window, Depreciation & Amortization - Total jumped 81.55% in 2023 and rose 0.47% in 2025, its largest moves.
• Year by year, Depreciation & Amortization - Total stood at $19923.5 in 2022, then surged by 81.55% to $36170.3 in 2023, then rose by 0.75% to $36443.0 in 2024, then grew by 0.47% to $36615.2 in 2025.
• According to Business Quant data, Depreciation & Amortization - Total over the past three periods registered $36615.2, $36443.0, and $36170.3 for Q4 2025, Q4 2024, and Q4 2023 respectively.